Here is a description of your company. Proin ex id consectetur lobortis. Aliquam, velit vel faucibus dapibus, augue justo ullamcorper turpis, nec convallis metus nunc vel turpis.
All tagged Cancer
Twist Exome 2.0: A new and powerful exome panel with best-in-class performance for translational research and more
In the milieu of rushing blood, plasma, and cells, small wayward bits of DNA are easy to overlook. But stored within these scraps of genetic material, known as cell-free DNA (cfDNA), is information offering the earliest glimpses of cancer development. Being able to detect and understand these signals could dramatically improve our ability to detect and treat cancer before the disease has developed.
Analysis of biomarkers in biopsies helps identify breast cancer patients in need of urgent surgery or chemotherapy during COVID-19 pandemic.
RNA-seq is an essential research tool that holds exciting prospects for the early detection of cancer. However, in clinical samples highly abundant mRNA and rRNA sequences obscure rarer RNA subtypes that may hold the keys to early cancer detection, such as long non-coding RNA. Here we dive into recent research from the University of Ghent outlining the use of targeted RNA-seq to enrich lncRNA from various sample types and discuss how recent advances make target enrichment an invaluable tool for high-resolution RNA-seq experiments.
It’s rare for a gene to be elevated into public discussion, and even rarer for a gene’s importance to be highlighted by celebrities and world leaders. While each gene on the ACMG 59 is incredibly important, no other gene has captured the public eye quite like the BRCA genes.
Cancer is a scary topic, in part because people usually only hear about it after they (or someone they know) has developed it. But that doesn’t have to be the case.
